Avidity Biosciences (RNA)

• Market cap: $10.8B
• 1 day: -0.07%
• 5 days: -0.15%
• 1 month: 2.43%
• 3 months: 47.58%
• 6 months: 109.03%
• Year to date: 129.41%
• 1 year: 88.58%
• 5 years: 119.96%
• 10 years: 150.98%
• Sector: Healthcare
• Industry: Biotechnology

About: Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Employees: 391